Publications by authors named "Alberta Davis-Warren"

Claim this Profile
R
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity.
Bo Peng, Rebecca Voltan, Anthony D Cristillo, W Gregory Alvord, Alberta Davis-Warren

AIDS· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.
Jun Zhao, Rebecca Voltan, Bo Peng, Alberta Davis-Warren, V S Kalyanaraman

Virology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.
Bo Peng, Liqun Rejean Wang, Victor Raúl Gómez-Román, Alberta Davis-Warren, David C Montefiori

J Virol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro.
Jenice D'Costa, Judith Harvey-White, Pankaj Qasba, Advait Limaye, Christine R Kaneski, Alberta Davis-Warren

J Med Virol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.
Jenice D'Costa, Heidi M Brown, Priya Kundra, Alberta Davis-Warren, Suresh K Arya

J Gen Virol· February 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis